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10 middle carpal (MCJ), and 10 radiocarpal (RCJ) joints (n=40).
SF samples from group 3 horses were from 16 MCP, 6 metatar-
sophalangeal (MTP), 12 MCJ, and 10 RCJ (n= 44). Serum
CTX II was measured for all horses (n=124). SF and serum
CTX II concentrations were measured by an ELISA (Pre-Clinical
CartiLaps®) previously validated for use in equine serum and SF.
Differences between groups in serum and SF CTX II concen-
trations and the ratio (SF:serum) were evaluated using one-way
ANOVA with Tukey’s test for multiple pairwise comparisons. P <
0.05 was considered signiﬁcant.
Results: Concentrations of CTX II were signiﬁcantly elevated
in SF from all joints of horses with osteochondral fragmentation
compared to rested (P<0.05). Concentrations of CTX II were
signiﬁcantly elevated in SF from MCP/MTP and RCJ of horses
with osteochondral fragmentation compared to exercised horses
(P<0.05). There was no signiﬁcant difference in SF CTX II be-
tween rested and exercised horses for any of the joints analyzed.
Serum CTX II concentrations were signiﬁcantly lower in horses
with OC injury in MCJ and RCJ compared to rested horses
(P<0.01). Horses with MCJ OC injury had signiﬁcantly lower
serum CTX II concentrations than exercised horses (P<0.01),
but horses with RCJ and MCP/MTP OC injury did not. SF to
serum ratios (SF:serum) were signiﬁcantly higher in horses with
MCP/MTP and MCJ OC injury compared to rested and exer-
cised horses (P<0.001) (Fig. 1). A signiﬁcant difference was
found between MCJ and RCJ OC injury SF:serum (P<0.05).
Conclusions: These results strongly support the use of SF and
serum CTX II concentrations as a discriminating biomarker for
the diagnosis of OC injury in equine joints.
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Purpose: Several different type II collagen epitopes have been
described as potential biomarkers of onset and/or progression
of OA. Among the degradative markers, the C-telopeptide frag-
ment, CTXII, has the most abundant data supporting its use
as an arthritis marker. More recently, two serum immunoassays
have been developed to quantify a sequence derived from the
triple helical region of type II collagen, (Coll2-1) and its nitrated
form (Coll2-1 NO2), that can be used to quantify both cartilage
degradation as well as oxidative damage, respectively. In this
study, we investigated the utility of serum Coll2-1, Coll2-1 NO2
and CTXII in a well characterized cohort of Hartley guinea pigs.
Methods: Forty six male Hartley guinea pigs were sacriﬁced at
3 weeks, 2, 4, 7, 10, 12 and 18 months of age, at which time
blood samples were obtained. Histological severity of OA was
determined using a semi-quantitative grading scheme described
previously. Serum Coll2-1 and Coll2-1 NO2 were quantiﬁed by
competitive ELISA and serum CTXII were quantiﬁed using the
Serum Pre-clinical Cartilaps ELISA. This assay was designed to
detect degradation products of C-terminal telopeptides of type II
collagen in animal sera. Statistical analyses included: the non-
parametric Mann Whitney test to compare the levels of Coll2-1 at
3 weeks and 4 months of age, and correlations between Coll2-
1 and total histological score estimated by the non-parametric
Spearman’s rank correlation coefﬁcient. Data were considered
statistically signiﬁcant at p value < 0.05.
Results: CTXII and Coll2-1 displayed completely different time
course proﬁles (Fig. 1). At 3 weeks of age, CTXII was elevated
Figure 1
and rapidly declined to very low levels by 7 months of age,
showing very little change from 7-18 months of age. In contrast,
Coll2-1 displayed a nadir at 3 weeks, a 65% increase from 3
weeks to 4 months of age (p=0.002) with consistently elevated
levels thereafter to 18 months of age. The serum proﬁle for Coll2-
1NO2 was similar but concentrations equaled1-2% the serum
concentrations of Coll2-1 throughout the time course. The early
change in Coll2-1 correlated with an increase in OA histological
severity during this time interval (r=0.75, p=0.0004). Mean serum
Coll2-1 was signiﬁcantly different between the lowest quartile of
OA histological severity and the higher three quartiles (Fig. 2).
Figure 2
Conclusions: Although CTXII and Coll2-1 are both type II colla-
gen speciﬁc epitopes, it is clear that they reﬂect different biolog-
ical processes, probably as a result of differential expression of
collagen degradative enzymes in different joint tissue compart-
ments. For instance, the serum CTXII proﬁle in the guinea pig is
most compatible with collagen II turnover in the growth plate car-
tilage which ceases at 4 months of age in this model and is barely
measurable during the period of development of histological OA.
In contrast, the levels of Coll2-1 and Col2-1 NO2 are lowest
during the most active period of growth plate cartilage turnover,
increase markedly in young animals when collagen birefringence
data suggests collagen disruption is occurring, and remain ele-
vated during the course of disease development. These results
suggest that the Coll2-1 and Coll2-1NO2 epitopes are likely gen-
erated from articular cartilage and may be useful as quantitative
biomarker outcomes for early disease prevention and treatment
in this model system.
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Purpose: The goal of this study was to evaluate the relation-
ship between biological markers and osteoarthritis (OA) clinical
phenotypes in a large multigenerational family in the United
